Symbols / SDGR Stock $11.79 +3.33% Schrödinger, Inc.

Healthcare • Health Information Services • United States • NMS
SDGR (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Health Information Services
CEO Dr. Ramy Farid Ph.D.
Exch · Country NMS · United States
Market Cap 870.40M
Enterprise Value 584.24M
Income -103.27M
Sales 255.87M
FCF (ttm) 99.98M
Book/sh 4.94
Cash/sh 5.36
Employees 850
Insider 10d —
IPO Feb 06, 2020
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E —
Forward P/E -8.54
PEG —
P/S 3.40
P/B 2.39
P/C —
EV/EBITDA -3.63
EV/Sales 2.28
Quick Ratio 2.64
Current Ratio 2.75
Debt/Eq 30.03
LT Debt/Eq —
EPS (ttm) -1.41
EPS next Y -1.38
EPS Growth —
Revenue Growth -1.20%
EPS Gr Q/Q —
Rev Gr Q/Q —
Earnings (next) 2026-05-05
Earnings (prior) 2026-02-25
ROA -13.46%
ROE -26.29%
ROIC —
Gross Margin 55.74%
Oper. Margin -19.67%
Profit Margin -40.36%
Shs Outstand 64.66M
Shs Float 58.62M
Insider Own 3.23%
Instit Own 107.43%
Short Float 26.87%
Short Ratio 9.75
Short Interest 10.91M
52W High 27.63
vs 52W High -57.33%
52W Low 10.95
vs 52W Low 7.72%
Beta 1.62
Impl. Vol. 49.60%
Rel Volume 0.79
Avg Volume 1.47M
Volume 1.15M
Target (mean) $21.38
Tgt Median $20.00
Tgt Low $13.00
Tgt High $30.00
# Analysts 8
Recom Strong_buy
Prev Close $11.41
Price $11.79
Change 3.33%
About

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery. The Software segment sells its software to transform molecular discovery for life sciences and materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. It has a research collaboration and license agreement with Novartis Pharma AG to advance multiple development candidates. Schrödinger, Inc. was incorporated in 1990 and is based in New York, New York.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$21.38
Mean price target
2. Current target
$11.79
Latest analyst target
3. DCF / Fair value
$27.83
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$11.79
Low
$13.00
High
$30.00
Mean
$21.38

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-04-08 main Keybanc Overweight → Overweight $20
2026-03-17 main UBS Neutral → Neutral $13
2026-01-08 main TD Cowen Buy → Buy $24
2026-01-08 main Keybanc Overweight → Overweight $25
2026-01-07 init UBS — → Neutral $18
2025-12-15 up B of A Securities Neutral → Buy $24
2025-10-08 main Keybanc Overweight → Overweight $28
2025-09-30 init Goldman Sachs — → Neutral $19
2025-08-18 main Morgan Stanley Equal-Weight → Equal-Weight $19
2025-08-15 down Citigroup Buy → Neutral $20
2025-08-14 init Barclays — → Overweight $25
2025-07-14 main Keybanc Overweight → Overweight $30
2025-04-16 main Keybanc Overweight → Overweight $32
2025-02-27 main Piper Sandler Overweight → Overweight $45
2025-01-24 main Keybanc Overweight → Overweight $27
2024-11-13 main BMO Capital Outperform → Outperform $28
2024-10-17 main BMO Capital Outperform → Outperform $25
2024-08-21 main Morgan Stanley Equal-Weight → Equal-Weight $30
2024-07-11 main Keybanc Overweight → Overweight $25
2024-07-02 init Leerink Partners — → Outperform $29
News
RSS: Latest SDGR news
Insider Transactions
Filed Date Insider Relationship Transaction Shares Price Value SEC
2026-04-17 RAMY SAMIR FARID PH.D. Chief Executive Officer — 86,000 $12.21 $1,055,177
2026-04-17 RAMY SAMIR FARID PH.D. Chief Executive Officer — 160,527 $3.07 $492,818
2026-04-16 JAIN RACHIT Chief Financial Officer — 844 $12.75 $10,758
2026-03-06 HERMAN JENNY Officer — 1,383 $12.84 $17,764
2026-03-05 JAIN RACHIT Chief Financial Officer — 1,631 $12.90 $21,033
2026-03-05 LORTON KENNETH PATRICK Officer — 1,222 $12.90 $15,761
2026-03-05 TRAN YVONNE KIM Officer — 1,094 $12.90 $14,107
2026-03-05 FRIESNER RICHARD A Chief Executive Officer — 3,661 $12.91 $47,249
2026-03-05 AKINSANYA-AKIWUMI KAREN OLUFUNMILYO President — 1,366 $12.90 $17,625
2026-03-04 ABEL ROBERT LORNE Officer — 1,300 $12.81 $16,653
Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
255.87
+23.29%
207.54
-4.21%
216.67
+19.73%
180.96
Operating Revenue
255.87
+23.29%
207.54
-4.21%
216.67
+19.73%
180.96
Cost Of Revenue
113.25
+50.09%
75.46
-0.68%
75.97
-4.95%
79.93
Reconciled Cost Of Revenue
113.25
+50.09%
75.46
-0.68%
75.97
-4.95%
79.93
Gross Profit
142.61
+7.97%
132.08
-6.12%
140.69
+39.27%
101.02
Operating Expense
309.51
-9.34%
341.38
+7.30%
318.14
+28.37%
247.84
Research And Development
173.14
-14.20%
201.78
+11.01%
181.77
+43.83%
126.37
Selling General And Administration
136.37
-2.31%
139.59
+2.36%
136.37
+12.27%
121.47
Selling And Marketing Expense
40.96
+2.62%
39.92
+7.23%
37.23
+21.49%
30.64
General And Administrative Expense
95.41
-4.28%
99.68
+0.53%
99.15
+9.16%
90.83
Other Gand A
95.41
-4.28%
99.68
+0.53%
99.15
+9.16%
90.83
Total Expenses
422.76
+1.42%
416.83
+5.77%
394.11
+20.24%
327.77
Operating Income
-166.90
+20.26%
-209.30
-17.95%
-177.45
-20.86%
-146.82
Total Operating Income As Reported
-166.90
+20.26%
-209.30
-17.95%
-177.45
-20.86%
-146.82
EBITDA
-160.87
+20.81%
-203.14
-18.17%
-171.90
-20.65%
-142.47
Normalized EBITDA
-209.05
-0.11%
-208.82
+7.34%
-225.36
-81.17%
-124.39
Reconciled Depreciation
6.02
-2.22%
6.16
+10.93%
5.55
+27.81%
4.34
EBIT
-166.90
+20.26%
-209.30
-17.95%
-177.45
-20.86%
-146.82
Total Unusual Items
48.17
+747.69%
5.68
-89.37%
53.46
+395.63%
-18.08
Total Unusual Items Excluding Goodwill
48.17
+747.69%
5.68
-89.37%
53.46
+395.63%
-18.08
Net Income
-103.27
+44.81%
-187.12
-559.54%
40.72
+127.29%
-149.19
Pretax Income
-102.33
+44.90%
-185.71
-532.70%
42.92
+128.78%
-149.12
Net Non Operating Interest Income Expense
—
—
—
—
Net Interest Income
—
—
—
—
Interest Income Non Operating
—
—
—
—
Interest Income
—
—
—
—
Other Income Expense
64.57
+173.78%
23.59
-89.30%
220.37
+9656.24%
-2.31
Other Non Operating Income Expenses
16.40
-8.41%
17.90
-9.09%
19.69
+398.18%
3.95
Gain On Sale Of Security
48.17
+747.69%
5.68
-89.37%
53.46
+395.63%
-18.08
Tax Provision
0.94
-33.50%
1.41
-35.79%
2.20
+3390.48%
0.06
Tax Rate For Calcs
0.00
+0.00%
0.00
+311.76%
0.00
-75.71%
0.00
Tax Effect Of Unusual Items
10.12
+747.69%
1.19
-56.23%
2.73
+171.79%
-3.80
Net Income Including Noncontrolling Interests
-103.27
+44.81%
-187.12
-559.54%
40.72
+127.29%
-149.19
Net Income From Continuing Operation Net Minority Interest
-103.27
+44.81%
-187.12
-559.54%
40.72
+127.29%
-149.19
Net Income From Continuing And Discontinued Operation
-103.27
+44.81%
-187.12
-559.54%
40.72
+127.29%
-149.19
Net Income Continuous Operations
-103.27
+44.81%
-187.12
-559.54%
40.72
+127.29%
-149.19
Minority Interests
—
—
0.00
-100.00%
0.00
Normalized Income
-141.32
+26.25%
-191.61
-1813.35%
-10.01
+92.58%
-134.90
Net Income Common Stockholders
-103.27
+44.81%
-187.12
-559.54%
40.72
+127.29%
-149.19
Diluted EPS
-1.41
+45.14%
-2.57
-575.93%
0.54
+125.71%
-2.10
Basic EPS
-1.41
+45.14%
-2.57
-550.88%
0.57
+127.14%
-2.10
Basic Average Shares
73.44
+1.06%
72.67
+1.25%
71.78
+0.85%
71.17
Diluted Average Shares
73.44
+1.06%
72.67
-3.09%
74.99
+5.36%
71.17
Diluted NI Availto Com Stockholders
-103.27
+44.81%
-187.12
-559.54%
40.72
+127.29%
-149.19
Earnings From Equity Interest
0.00
0.00
-100.00%
147.21
+1144.93%
11.82
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
726.16
-11.79%
823.23
+2.52%
802.96
+16.61%
688.59
Current Assets
519.26
-18.23%
634.99
+11.83%
567.80
+6.33%
533.99
Cash Cash Equivalents And Short Term Investments
395.46
+12.31%
352.12
-23.95%
463.00
+2.64%
451.09
Cash And Cash Equivalents
230.52
+56.47%
147.33
-5.14%
155.31
+71.67%
90.47
Other Short Term Investments
164.95
-19.46%
204.80
-33.44%
307.69
-14.68%
360.61
Receivables
104.39
-59.11%
255.33
+186.52%
89.12
+28.99%
69.09
Accounts Receivable
83.04
-64.77%
235.69
+257.15%
65.99
+17.94%
55.95
Gross Accounts Receivable
83.48
-64.61%
235.90
+256.28%
66.21
+18.07%
56.08
Allowance For Doubtful Accounts Receivable
-0.44
-109.52%
-0.21
+4.55%
-0.22
-76.00%
-0.12
Other Receivables
21.35
+8.71%
19.64
-15.06%
23.12
+76.02%
13.14
Prepaid Assets
12.54
+2.74%
12.21
+22.96%
9.93
+15.84%
8.57
Restricted Cash
6.87
-55.20%
15.33
+166.58%
5.75
+9.69%
5.24
Total Non Current Assets
206.90
+9.91%
188.23
-19.96%
235.16
+52.11%
154.60
Net PPE
122.19
-10.21%
136.08
-3.56%
141.10
+17.36%
120.23
Gross PPE
147.19
-6.21%
156.93
-1.46%
159.25
+18.55%
134.34
Accumulated Depreciation
-25.00
-19.87%
-20.85
-14.90%
-18.15
-28.60%
-14.11
Properties
0.00
0.00
0.00
0.00
Machinery Furniture Equipment
29.54
-2.84%
30.40
+7.23%
28.35
+8.83%
26.05
Other Properties
114.00
-7.19%
122.84
-3.36%
127.11
+19.85%
106.06
Leases
3.65
-1.22%
3.69
-2.48%
3.79
+69.90%
2.23
Goodwill And Other Intangible Assets
4.79
+0.00%
4.79
+0.00%
4.79
-10.91%
5.38
Goodwill
4.79
+0.00%
4.79
+0.00%
4.79
+0.00%
4.79
Other Intangible Assets
—
—
—
0.59
Investments And Advances
73.65
+70.45%
43.21
-48.10%
83.25
+224.15%
25.68
Long Term Equity Investment
73.65
+70.45%
43.21
-48.10%
83.25
+224.15%
25.68
Other Non Current Assets
6.26
+50.78%
4.16
-30.91%
6.01
+81.64%
3.31
Total Liabilities Net Minority Interest
362.11
-9.87%
401.78
+57.93%
254.40
+5.70%
240.68
Current Liabilities
189.14
-1.36%
191.75
+43.44%
133.67
+22.86%
108.80
Payables And Accrued Expenses
59.87
-5.04%
63.05
+4.08%
60.57
+51.96%
39.86
Payables
11.45
+7.37%
10.67
-36.57%
16.82
+77.56%
9.47
Accounts Payable
11.45
+7.37%
10.67
-36.57%
16.82
+77.56%
9.47
Current Accrued Expenses
48.42
-7.57%
52.38
+19.71%
43.76
+43.98%
30.39
Current Debt And Capital Lease Obligation
16.41
-2.05%
16.75
-0.67%
16.87
+53.26%
11.01
Current Capital Lease Obligation
16.41
-2.05%
16.75
-0.67%
16.87
+53.26%
11.01
Current Deferred Liabilities
112.85
+0.81%
111.94
+99.08%
56.23
-2.93%
57.93
Current Deferred Revenue
112.85
+0.81%
111.94
+99.08%
56.23
-2.93%
57.93
Total Non Current Liabilities Net Minority Interest
172.97
-17.65%
210.03
+73.98%
120.72
-8.46%
131.88
Long Term Debt And Capital Lease Obligation
92.82
-8.17%
101.07
-8.95%
111.01
+5.24%
105.48
Long Term Capital Lease Obligation
92.82
-8.17%
101.07
-8.95%
111.01
+5.24%
105.48
Non Current Deferred Liabilities
78.88
-27.51%
108.81
+1103.30%
9.04
-64.67%
25.60
Non Current Deferred Revenue
78.88
-27.51%
108.81
+1103.30%
9.04
-64.67%
25.60
Other Non Current Liabilities
1.28
+775.34%
0.15
-78.11%
0.67
-16.63%
0.80
Stockholders Equity
364.05
-13.62%
421.44
-23.17%
548.56
+22.47%
447.89
Common Stock Equity
364.05
-13.62%
421.44
-23.17%
548.56
+22.47%
447.89
Capital Stock
0.74
+1.10%
0.73
+0.97%
0.72
+1.12%
0.71
Common Stock
0.74
+1.10%
0.73
+0.97%
0.72
+1.12%
0.71
Preferred Stock
0.00
0.00
0.00
0.00
Share Issued
73.68
+1.10%
72.87
+1.02%
72.14
+1.14%
71.33
Ordinary Shares Number
73.68
+1.10%
72.87
+1.02%
72.14
+1.14%
71.33
Additional Paid In Capital
992.01
+4.86%
946.04
+6.78%
885.97
+6.91%
828.70
Retained Earnings
-628.81
-19.65%
-525.54
-55.29%
-338.42
+10.74%
-379.14
Gains Losses Not Affecting Retained Earnings
0.11
-51.36%
0.22
-21.71%
0.28
+111.80%
-2.38
Minority Interest
—
—
0.00
-100.00%
0.01
Other Equity Adjustments
0.11
-51.36%
0.22
-21.71%
0.28
+111.80%
-2.38
Total Equity Gross Minority Interest
364.05
-13.62%
421.44
-23.17%
548.56
+22.47%
447.90
Total Capitalization
364.05
-13.62%
421.44
-23.17%
548.56
+22.47%
447.89
Working Capital
330.13
-25.52%
443.25
+2.10%
434.12
+2.10%
425.19
Invested Capital
364.05
-13.62%
421.44
-23.17%
548.56
+22.47%
447.89
Total Debt
109.23
-7.30%
117.83
-7.86%
127.88
+9.78%
116.49
Capital Lease Obligations
109.23
-7.30%
117.83
-7.86%
127.88
+9.78%
116.49
Net Tangible Assets
359.26
-13.77%
416.65
-23.38%
543.77
+22.88%
442.52
Tangible Book Value
359.26
-13.77%
416.65
-23.38%
543.77
+22.88%
442.52
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
13.90
+108.83%
-157.37
-15.09%
-136.73
-14.25%
-119.68
Cash Flow From Continuing Operating Activities
13.90
+108.83%
-157.37
-15.09%
-136.73
-14.25%
-119.68
Net Income From Continuing Operations
-103.27
+44.81%
-187.12
-559.54%
40.72
+127.29%
-149.19
Depreciation Amortization Depletion
6.02
-2.22%
6.16
+10.93%
5.55
+27.81%
4.34
Depreciation
—
—
—
—
Depreciation And Amortization
6.02
-2.22%
6.16
+10.93%
5.55
+27.81%
4.34
Other Non Cash Items
—
—
—
—
Stock Based Compensation
43.00
-13.84%
49.90
+4.31%
47.84
+20.72%
39.63
Operating Gains Losses
-48.15
-602025.00%
0.01
+100.01%
-147.07
-1145.73%
-11.81
Gain Loss On Investment Securities
—
-5.68
+89.37%
-53.46
-395.63%
18.08
Unrealized Gain Loss On Investment Securities
—
-5.68
+89.37%
-53.46
-395.63%
18.08
Gain Loss On Sale Of PPE
0.02
+150.00%
0.01
-94.37%
0.14
+647.37%
0.02
Change In Working Capital
118.17
+1006.18%
-13.04
+42.18%
-22.55
-5.50%
-21.38
Change In Receivables
150.94
+190.81%
-166.22
-730.01%
-20.03
+28.35%
-27.95
Changes In Account Receivables
152.65
+189.95%
-169.70
-1590.41%
-10.04
+57.64%
-23.70
Change In Prepaid Assets
-2.44
+29.78%
-3.48
+58.85%
-8.46
-19.74%
-7.07
Change In Payables And Accrued Expense
-1.85
-180.80%
2.29
-88.64%
20.12
+216.59%
6.36
Change In Accrued Expense
-2.75
-132.78%
8.40
-34.33%
12.80
+147.26%
5.18
Change In Payable
0.91
+114.84%
-6.12
-183.58%
7.32
+520.95%
1.18
Change In Account Payable
0.91
+114.84%
-6.12
-183.58%
7.32
+520.95%
1.18
Change In Other Working Capital
-29.03
-118.67%
155.48
+951.69%
-18.26
-859.33%
-1.90
Change In Other Current Assets
9.15
+2.29%
8.94
+15.14%
7.77
+6.57%
7.29
Change In Other Current Liabilities
-8.60
+14.44%
-10.05
-172.14%
-3.69
-294.42%
1.90
Investing Cash Flow
57.90
-61.10%
148.84
-22.90%
193.03
+114.43%
90.02
Cash Flow From Continuing Investing Activities
57.90
-61.10%
148.84
-22.90%
193.03
+114.43%
90.02
Net PPE Purchase And Sale
-1.44
+80.28%
-7.31
+45.45%
-13.40
-67.24%
-8.01
Purchase Of PPE
-1.44
+80.28%
-7.31
+45.45%
-13.40
-67.24%
-8.01
Capital Expenditure
-1.44
+80.28%
-7.31
+45.45%
-13.40
-67.24%
-8.01
Net Investment Purchase And Sale
41.60
-62.32%
110.42
+74.31%
63.35
-32.06%
93.24
Purchase Of Investment
-312.96
-24.52%
-251.34
+21.61%
-320.62
-18.11%
-271.47
Sale Of Investment
354.56
-1.99%
361.76
-5.79%
383.97
+5.28%
364.71
Net Business Purchase And Sale
17.73
-61.21%
45.73
+1208.51%
-4.12
+41.30%
-7.03
Purchase Of Business
0.00
+100.00%
-3.07
+25.53%
-4.12
+41.30%
-7.03
Financing Cash Flow
2.93
-71.05%
10.12
+11.88%
9.05
+328.82%
2.11
Cash Flow From Continuing Financing Activities
2.93
-71.05%
10.12
+11.88%
9.05
+328.82%
2.11
Net Issuance Payments Of Debt
-0.06
+0.00%
-0.06
-205.26%
-0.02
0.00
Repayment Of Debt
-0.06
+0.00%
-0.06
-205.26%
-0.02
0.00
Long Term Debt Payments
-0.06
+0.00%
-0.06
-205.26%
-0.02
0.00
Net Long Term Debt Issuance
-0.06
+0.00%
-0.06
-205.26%
-0.02
0.00
Net Common Stock Issuance
0.00
-100.00%
8.87
0.00
0.00
Proceeds From Stock Option Exercised
2.99
+100.60%
1.49
-84.22%
9.44
+347.39%
2.11
Net Other Financing Charges
—
-0.18
+52.55%
-0.37
—
Changes In Cash
74.73
+4596.92%
1.59
-97.57%
65.35
+337.20%
-27.55
Beginning Cash Position
162.66
+0.99%
161.07
+68.27%
95.72
-22.35%
123.27
End Cash Position
237.38
+45.94%
162.66
+0.99%
161.07
+68.27%
95.72
Free Cash Flow
12.46
+107.56%
-164.68
-9.69%
-150.14
-17.57%
-127.70
Income Tax Paid Supplemental Data
—
1.08
-61.81%
2.83
+259.34%
0.79
Amortization Of Securities
-1.87
+75.41%
-7.59
+2.18%
-7.76
-1333.86%
0.63
Common Stock Issuance
0.00
-100.00%
8.87
0.00
0.00
Dividends Received CFI
0.00
0.00
-100.00%
147.21
+1144.93%
11.82
Earnings Losses From Equity Investments
-48.17
0.00
+100.00%
-147.21
-1144.93%
-11.82
Issuance Of Capital Stock
0.00
-100.00%
8.87
0.00
0.00
Net Preferred Stock Issuance
—
—
—
—
Preferred Stock Issuance
—
—
—
—
Sale Of Business
17.73
-63.66%
48.80
0.00
0.00
SEC Filings

Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category